Sleep disturbance as a poor prognostic predictor in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A prospective study.

Ning LiDinglong XueXu ZhaoLijun LiKaiya MenJiaxin YangHao JiangQingwei MengShuai Zhang

Published in: Journal of psychosomatic research (2024)

Sleep disturbance could be a factor for prognosis in patients with advanced NSCLC undergoing first- or second-line treatment with ICIs, including shorter PFS and reduced efficacy.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
sleep quality
physical activity
small cell lung cancer
tyrosine kinase
depressive symptoms
replacement therapy